Skip to search formSkip to main contentSkip to account menu

natalizumab

Known as: Anti-VLA4, Anti-alpha4 integrin, Natalizumab [Chemical/Ingredient] 
A humanized recombinant IgG4 monoclonal antibody directed against the alpha4 subunit of the integrins alpha4beta1and alpha4beta7 with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
2011
2011
Hoevenaren IA, de Vries LC, Rijnders RJP, Lotgering FK. Delivery of healthy babies after natalizumab use for multiple sclerosis… 
Review
2006
Review
2006
Purpose of reviewMultiple sclerosis affects many people, often in early adulthood, and causes significant disability. Natalizumab… 
2005
2005
A recent Keystone meeting highlighted the progress in generating effective anti-cancer antibodies by manipulating antibody… 
2003
2003
Poly(ethylene glycol):poly(acrylate) PEG-g-PA co-polymers were made that inhibited nonspecific protein and cellular adhesion. PEG… 
1997
1997
We have previously reported that propolypeptide of von Willebrand factor (pp-vWF) promotes melanoma cell adhesion in a β1… 
1997
1997
Tumor necrosis factor α (TNFα) is a cytokine implicated in the pathogenesis of numerous chronic and acute inflammatory conditions…